Advertisement

Topics

France's Cellectis told to pause cell therapy tests after death

23:14 EDT 4 Sep 2017 | Reuters

LONDON (Reuters) - French cell therapy specialist Cellectis, which is developing a gene-modified cancer treatment similar to Novartis's recently approved Kymriah, has been forced to suspend testing following a patient death.

Original Article: France's Cellectis told to pause cell therapy tests after death

NEXT ARTICLE

More From BioPortfolio on "France's Cellectis told to pause cell therapy tests after death"

Quick Search
Advertisement
 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...